On the fly News and insights, exclusive to thefly.com

PTON

Peloton

$82.29 /

-0.29 (-0.35%)

, FMC

FMC Corporation

$113.89 /

-8.07 (-6.62%)

09:54
05/06/21
05/06
09:54
05/06/21
09:54

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Peloton (PTON) downgraded to Neutral from Buy at BofA with analyst Justin Post saying Peloton's voluntary recall of both the Tread and Tread+ treadmills change his "upside thesis," said Post, who said his biggest concern on the news is not the potential loss of Tread+ subscribers but the potential impact on the launch of the new lower-priced Tread, which he had previously anticipated would be a significant growth driver in FY22. 2. FMC Corporation (FMC) downgraded to Neutral from Buy at Citi with analyst P.J. Juvekar saying the company reported a "somewhat weak quarter" in terms of organic growth. 3. Pfizer (PFE) downgraded to Neutral from Buy at Mizuho with analyst Vamil Divan saying the company delivered a "stunning beat and raise" in Q1, but the recent strength in the shares make meaningful upside more challenging. 4. OceanFirst Financial (OCFC) downgraded to Equal Weight from Overweight at Stephens with analyst Matt Breese saying despite a Q4 balance sheet restructuring that was expected to result in 15 basis points of net interest margin expansion, NIM disappointed in Q1 and the "pathway to a 1.00% ROA appears beyond 2022." 5. Pioneer Natural (PXD) downgraded to Hold from Buy at Truist with analyst Neal Dingmann noting that his rating change is driven by the "fear of change" in the "ever-changing energy investor appetite," even though the company's longer-term metrics are toward the top of the industry. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

PTON

Peloton

$82.29 /

-0.29 (-0.35%)

FMC

FMC Corporation

$113.89 /

-8.07 (-6.62%)

PFE

Pfizer

$38.30 /

-1.28 (-3.23%)

OCFC

OceanFirst Financial

$22.86 /

-0.02 (-0.09%)

PXD

Pioneer Natural

$163.40 /

-1.04 (-0.63%)

  • 06

    May

  • 06

    May

  • 11

    May

  • 19

    May

  • 24

    May

  • 27

    May

  • 29

    Dec

PTON Peloton
$82.29 /

-0.29 (-0.35%)

05/05/21 BofA
Peloton downgraded to Neutral after 'thesis changing' recalls at BofA
05/05/21 BofA
Peloton downgraded to Neutral from Buy at BofA
05/05/21 BMO Capital
BMO Capital continues to worry Peloton shares will catch down to fundamentals
05/05/21 JPMorgan
JPMorgan sees Peloton shares remaining under pressure
FMC FMC Corporation
$113.89 /

-8.07 (-6.62%)

05/06/21 Citi
FMC Corporation downgraded to Neutral from Buy at Citi
02/11/21 Monness Crespi
FMC Corporation upgraded to Buy from Neutral at Monness Crespi
01/20/21 RBC Capital
FMC Corporation price target lowered to $136 from $145 at RBC Capital
01/20/21 Citi
Citi adds PPG to US Focus List, removes FMC
PFE Pfizer
$38.30 /

-1.28 (-3.23%)

05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
OCFC OceanFirst Financial
$22.86 /

-0.02 (-0.09%)

05/06/21 Stephens
OceanFirst downgraded to Equal Weight at Stephens after NIM disappoints
05/06/21 Stephens
OceanFirst Financial downgraded to Equal Weight from Overweight at Stephens
03/24/21 Seaport Global
OceanFirst Financial initiated with a Buy at Seaport Global
03/24/21 Seaport Global
OceanFirst Financial initiated with a Buy at Seaport Global
PXD Pioneer Natural
$163.40 /

-1.04 (-0.63%)

05/06/21 Truist
Pioneer Natural downgraded to Hold from Buy at Truist
05/06/21 Truist
Pioneer Natural downgraded to Hold from Buy at Truist
04/23/21 Wolfe Research
Pioneer Natural downgraded to Peer Perform from Outperform at Wolfe Research
04/19/21 Truist
Pioneer Natural price target raised to $190 from $175 at Truist

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.